FUT2 Secretor Status Is Not Associated With Oral Poliovirus Vaccine Immunogenicity in South Indian Infants

J Infect Dis. 2019 Jan 29;219(4):578-581. doi: 10.1093/infdis/jiy553.

Abstract

FUT2 determines whether histo-blood group antigens are secreted at mucosal surfaces. Secretor status influences susceptibility to enteric viruses, potentially including oral poliovirus vaccine (OPV). We performed a nested case-control study to determine the association between FUT2 genotype (single-nucleotide polymorphisms G428A, C302T, and A385T) and seroconversion among Indian infants who received a single dose of monovalent type 3 OPV. Secretor prevalence was 75% (89 of 118) in infants who seroconverted and 80% (97 of 122) in infants who did not seroconvert (odds ratio, 0.79; 95% confidence interval, .43-1.45). Our findings suggest that FUT2 genotype is not a key determinant of variation in OPV immunogenicity.

Publication types

  • Randomized Controlled Trial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Case-Control Studies
  • Female
  • Fucosyltransferases / genetics*
  • Galactoside 2-alpha-L-fucosyltransferase
  • Genotype*
  • Humans
  • Immunogenicity, Vaccine / genetics*
  • India
  • Infant
  • Male
  • Poliomyelitis / prevention & control*
  • Poliovirus Vaccine, Oral / immunology*

Substances

  • Poliovirus Vaccine, Oral
  • Fucosyltransferases